Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Third Rock Ventures at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Third Rock Ventures takes part in 3 sessions at SITC 2026 in Phoenix. Its program focuses on financing and partnering for biotech companies and on bringing emerging technologies into clinical trials.

OrganizationSITC 2026 Attendance
Investors
Venture capital firm that founds, builds and invests in biotechnology companies.
Workshop
Thu Nov 5
8:00am–4:15pm
New Agents in Development and Emerging Technologies
  1. 8:00am–9:50amSession I: Cell Therapies and Technologies
  2. 10:05am–11:50amSession II: Immune Cell Engagers and Bispecifics
  3. 1:30pm–2:55pmSession III: ADC/iADC
  4. 3:10pm–4:15pmSession IV: Emerging Technologies – Incorporation into Clinical Trials
Workshop
Thu Nov 5
3:10pm–4:15pm
Session IV: Emerging Technologies – Incorporation into Clinical Trials
Clinical
  1. 3:10pm–3:25pmIn vivo and Solid Tumor CAR-T Cell TherapiesUCSF
  2. 3:25pm–3:40pmAcademic and Industry Collaborations
  3. 3:40pm–3:55pmARO/PACT StructureMount Sinai Hospital
Session
Thu Nov 5
7:00pm–7:50pm
Financing and Partnership Panel
Regulatory

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Third Rock Ventures

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction